Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a

Elaine Wirrell1, Lily Wong-Kisiel, Jay Mandrekar

  • 1Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. wirrell.elaine@mayo.edu

Epilepsia
|June 29, 2012
PubMed

Insights

One third of young children with epilepsy before 36 months develop medically intractable seizures, predicted by early diagnosis and developmental issues. This intractable epilepsy significantly increases mortality and intellectual disability risks.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Epidemiology

Background:

  • Epilepsy in early childhood presents unique challenges.
  • Understanding medical intractability is crucial for long-term outcomes.

Purpose of the Study:

  • Determine the prevalence of medically intractable epilepsy in children diagnosed before 36 months.
  • Identify predictors of medical intractability.
  • Assess the impact of intractable epilepsy on mortality and intellectual function.

Main Methods:

  • Retrospective cohort study of 127 children with new-onset epilepsy before 36 months (1980-2009).
  • Medical records reviewed for epilepsy variables and outcomes.
  • Medically intractable epilepsy defined by persistent seizures or epilepsy surgery after medication failure.

Main Results:

  • 35% of children developed medically intractable epilepsy.
  • Predictors included diagnosis at ≤12 months, developmental delay, neuroimaging abnormalities, and focal EEG slowing.
  • Intractable epilepsy was associated with significantly higher mortality (20% vs. 0%) and poorer intellectual outcomes.

Conclusions:

  • Medically intractable epilepsy affects one-third of young children with epilepsy.
  • Early identification of predictors is key.
  • Intractable epilepsy significantly elevates mortality and intellectual disability risks.
Abstract

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...